heighten
surveil
acut
febril
ill
china
sinc
led
identif
sever
fever
thrombocytopenia
syndrom
sft
unknown
etiolog
sporad
patient
hospit
sft
identifi
serum
sampl
collect
sequenc
novel
speci
phleboviru
identifi
sequenc
independ
singl
primer
amplif
sispa
serum
patient
sft
viru
isol
vero
cell
cultur
complet
genom
sequenc
determin
distantli
relat
known
phlebovirus
electron
microscop
analysi
reveal
virion
morpholog
characterist
phlebovirus
viru
name
sft
viru
viral
rna
andor
specif
antibodi
detect
blood
patient
sft
serolog
assay
demonstr
virusspecif
immun
respons
pair
sera
collect
patient
acut
convalesc
phase
pathogen
mechan
thrombocytopenia
human
sft
diseas
resembl
mous
model
result
collect
demonstr
sft
viru
etiolog
associ
acut
novel
infecti
diseas
sft
human
surveil
infecti
diseas
china
significantli
enhanc
sinc
outbreak
sever
acut
respiratori
syndrom
sar
year
sporad
case
sever
acut
febril
ill
unidentifi
caus
note
uniqu
group
hospit
patient
suffer
acut
high
fever
accompani
thrombocytopenia
identifi
although
anaplasma
phagocytophilum
found
case
zhang
et
al
suggest
caus
diseas
neither
bacteri
dna
antibodi
bacterium
could
detect
major
patient
within
group
infecti
caus
includ
bunyavirus
includ
hantaviru
rift
valley
fever
viru
toscana
viru
crimeancongo
hemorrhag
fever
viru
flavivirus
includ
dengu
viru
filoviru
ebola
viru
marburg
viru
arenavirus
includ
lassa
viru
junin
viru
alphaviru
rickettsia
also
exclud
revers
transcriptionpolymeras
chain
reaction
rtpcr
andor
specif
antibodi
test
found
case
wood
hilli
upland
area
patient
mostli
farmer
ever
work
field
onset
diseas
view
unusu
find
activ
surveil
implement
sever
provinc
china
sinc
may
identifi
patient
sever
fever
thrombocytopenia
syndrom
sft
character
acut
high
fever
thrombocytopenia
collect
sera
subject
sequenc
independ
singl
primer
amplif
sispa
provid
opportun
discov
novel
microbi
agent
directli
clinic
sampl
alland
et
al
victoria
et
al
ambros
clewley
jone
et
al
novel
phleboviru
identifi
subsequ
isol
cell
cultur
complet
genom
novel
viru
sequenc
molecular
serolog
assay
perform
detect
viru
larger
cohort
patient
sft
relat
data
publish
yu
et
al
describ
process
discoveri
sft
viru
china
activ
surveil
scheme
implement
select
area
hubei
henan
provinc
sinc
may
identifi
hospit
patient
present
acut
fever
thrombocytopenia
unknown
caus
nation
serum
sampl
collect
prefer
within
week
onset
fever
convalesc
phase
six
provinc
hubei
henan
shandong
jiangsu
anhui
liaon
case
sft
occur
may
also
identifi
retrospect
review
sera
collect
request
hospit
case
fit
criteria
clinic
laboratori
confirm
diagnosi
exclud
sera
patientmatch
healthi
donor
live
area
also
collect
research
protocol
approv
human
bioethic
committe
chines
cdc
human
particip
gave
written
inform
consent
amplif
microbi
nucleic
acid
serum
base
modifi
version
sispa
method
alland
et
al
ambros
clewley
jone
et
al
filtrat
filter
digest
turbo
dnase
ambion
benzonas
novagen
rnase
one
promega
rna
extract
serum
patient
rna
prepar
revers
transcrib
cdna
second
strand
cdna
synthes
purif
dna
ligat
phosphoryl
blunt
adapt
ligat
product
pcr
amplifi
separ
agaros
gel
electrophoresi
fragment
differ
size
isol
clone
total
cdna
clone
pick
sispa
serum
patient
sequenc
trim
remov
sequenc
deriv
amplif
primer
data
set
subject
homolog
search
genbank
databas
nucleic
acid
protein
use
blastn
blastx
wherea
nucleotid
sequenc
essenti
unrel
sequenc
exist
genebank
databas
http
blastncbinlmgov
deduc
amino
acid
sequenc
cdna
clone
show
homolog
viral
protein
includ
rna
depend
rna
polymeras
rdrp
membran
polyprotein
nonstructur
protein
known
phlebovirus
rift
valley
fever
viru
uukuniemi
viru
walk
primer
direct
design
base
sequenc
gene
fragment
obtain
sispa
three
genom
segment
assembl
seri
overlap
cdna
clone
termini
viral
rna
segment
determin
rapid
amplif
cdna
end
race
use
reagent
purchas
invitrogen
elimin
influenc
clone
bia
genom
sequenc
direct
pcr
resequenc
three
genom
segment
perform
newli
design
primer
partial
sequenc
obtain
first
isol
viru
strain
dbm
complet
genom
isol
sft
viru
sequenc
yu
et
al
isol
includ
strain
dbm
close
relat
yu
et
al
termini
three
genom
segment
sft
viru
found
similar
counterpart
phlebovirus
phylogenet
analys
perform
neighborjoin
method
use
poisson
correct
complet
delet
gap
bootstrap
valu
estim
replic
confid
random
seed
phylogenet
tree
base
complet
viral
genom
sequenc
l
segment
strain
provinc
china
comparison
known
phlebovirus
show
sft
viru
relat
prototyp
virus
phleboviru
phylogenet
analysi
use
deduc
amino
acid
sequenc
rdrp
glycoprotein
gn
gc
n
nss
protein
gener
phylogenet
tree
show
sft
viru
isol
cluster
togeth
almost
equal
distant
two
group
fisher
et
al
includ
sandfli
fever
group
rift
valley
fever
punta
toro
toscana
massila
sandfli
fever
sicilian
virus
uukuniemi
group
comparison
amino
acid
sequenc
similar
provid
support
separ
sft
viru
phlebovirus
sft
viru
assign
novel
speci
genu
phleboviru
bunyaviriad
resign
novel
speci
genu
phleboviru
famili
phenuivirida
intern
committe
taxonomi
virus
ictv
june
blood
sampl
heparin
anticoagul
collect
day
onset
ill
patient
xinyang
citi
henan
provinc
due
lack
knowledg
caus
ill
pathogen
isol
inocul
multipl
cell
line
suscept
viral
rickettsi
agent
includ
vero
vero
cell
tick
cell
line
patient
white
blood
cell
inocul
cell
monolay
cell
cultur
co
atmospher
medium
chang
twice
week
month
inocul
cell
white
blood
cell
wbc
patient
cytopath
effect
cpe
observ
cell
morpholog
infect
cell
chang
round
monocyt
fibroblastlik
shape
granular
particl
cytoplasm
continu
cultur
cpe
usual
appear
day
inocul
fresh
monolay
pathogen
character
clearli
subsequ
viru
isol
inocul
vero
cell
serum
homogen
wbc
incub
day
cultur
fluid
passag
new
monolay
cell
monitor
daili
presenc
viral
rna
supernat
realtim
pcr
novel
phleboviru
isol
cultur
vero
cell
inocul
acutephas
serum
patient
shuizhou
area
hubei
provinc
viru
isol
also
success
sera
patient
sft
provinc
viral
rna
detect
realtim
rtpcr
day
inocul
immunoreact
infect
cell
convalescentphas
serum
collect
rtpcr
confirm
patient
observ
punctat
stain
pattern
distribut
evenli
throughout
infect
cell
day
inocul
plaqu
assay
perform
vero
cell
quantifi
infecti
particl
supernat
plaqu
visual
stain
neutral
red
solut
molten
agaros
viru
titer
pfuml
cultur
supernat
passag
viru
negativestain
electron
microscopi
reveal
sft
viru
particl
nm
diamet
complex
surfac
project
surround
peripheri
transmiss
electron
microscopi
tem
reveal
viral
particl
cell
cytoplasm
virus
observ
insid
vacuol
presum
golgi
apparatu
indirect
immunofluoresc
assay
ifa
enzymelink
immunosorb
assay
elisa
microneutr
test
use
detect
specif
antibodi
blood
patient
sft
ifa
fix
vero
cell
incub
dilut
human
serum
stain
fluorescein
label
antihuman
igg
antibodi
elisa
method
develop
purifi
recombin
nucleocapsid
protein
np
viru
produc
e
coli
specif
sensit
cross
reactiv
method
verifi
serum
sampl
collect
patient
sft
confirm
rtpcr
sera
collect
healthi
donor
area
without
report
sft
case
microneutr
test
sera
mix
equal
volum
tissu
cultur
infecti
dose
tcid
sft
viru
isol
incub
h
mixtur
ad
plate
quadrupl
plate
incub
co
day
viral
infect
well
detect
specif
ifa
assay
confirm
patient
serum
endpoint
titer
express
reciproc
highest
dilut
serum
viral
rna
detect
serum
whole
blood
homogen
arthropod
onestep
realtim
rtpcr
assay
use
primer
probe
design
base
viral
genom
segment
cutoff
ct
valu
posit
sampl
set
cycl
sampl
one
genom
segment
significantli
amplifi
verifi
nest
rtpcr
sequenc
sft
viral
rna
andor
specif
antibodi
detect
hospit
sft
patient
diagnos
accord
sft
case
definit
nation
patient
found
central
northeastern
area
china
includ
henan
case
hubei
case
shandong
case
anhui
case
jiangsu
case
liaon
provinc
case
viral
rna
specif
antibodi
detect
sera
collect
patientmatch
healthi
donor
endem
area
healthi
donor
nonendem
area
hfr
suspect
case
viral
rna
found
mosquito
captur
area
sft
patient
live
hand
tick
speci
haemaphysali
longicorni
collect
domest
anim
area
posit
sft
viru
rna
explor
seroconvers
sft
viru
patient
sft
cohort
rtpcrconfirm
patient
select
sera
acuteand
convalescentphas
collect
specif
antibodi
quantifi
use
ifa
elisa
microneutr
test
four
fold
elev
antibodi
titer
seroconvers
neg
posit
reactiv
serolog
test
found
patient
indic
hightit
neutral
antibodi
gener
convalesc
phase
diseas
antibodi
titer
elisa
found
sera
patient
convalesc
phase
indic
robust
humor
immun
respons
sft
viru
discoveri
new
sft
viru
result
joint
effort
virologist
clinician
epidemiologist
also
depend
progress
laboratori
test
technolog
robust
epidemiolog
clinic
serolog
virolog
data
collect
support
sft
viru
caus
sft
diseas
identifi
centraleastern
northeastern
part
china
cours
sft
diseas
singl
caus
addit
noninfecti
diseas
varieti
known
microbi
pathogen
caus
sft
need
differenti
relat
pathogen
